Biosimilars and access to biologic therapy in immune-mediated diseases.
Article in Expert Opinion on Biological Therapy (May 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
Article in Scientific Reports (August 2023)
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis
Article in JAMA Network Open (May 2023)